Westermann, Dirk
Ludwig, Sebastian http://orcid.org/0000-0002-5752-4951
Kalbacher, Daniel
Spink, Clemens
Linder, Matthias
Bhadra, Oliver D.
Nikorowitsch, Julius
Waldschmidt, Lara
Demal, Till
Voigtländer, Lisa
Schaefer, Andreas
Seiffert, Moritz
Pecha, Simon
Schofer, Niklas
Greenbaum, Adam B.
Reichenspurner, Hermann
Blankenberg, Stefan
Conradi, Lenard
Schirmer, Johannes
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 30 March 2021
Accepted: 26 May 2021
First Online: 22 June 2021
Change Date: 4 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00392-021-01904-0
Declarations
:
: DW reports personal fees from AstraZeneca, Bayer, Berlin-Chemie and Novartis. SL reports non-financial support from Edwards Lifesciences. DK has received lecture fees and travel support from Abbott and lecture as well as proctor fees and travel support from Edwards Lifesciences. MS reports non-financial support from Abbott, Biotronik, Boehringer Ingelheim, Boston Scientific, Edwards Lifesciences, Nicolai Medizintechnik, OrbusNeich Medical, personal fees from Abiomed, Amgen, AstraZeneca, Bayer Healthcare, Bristol-Myers Squibb, Boston Scientific, Medtronic, Philips and Shockwave Medical and grants from Philips. NS reports personal fees from Boston Scientific and non-financial support from Abbott and Edwards Lifesciences. SB reports grants and personal fees from Abbott, Bayer and Thermo Fisher, grants from SIEMENS and Singulex, personal fees from Abbott, Astra Zeneca AMGEN, Medtronic, Pfizer, Roche, Novartis and Siemens Diagnostics. LC is proctor and consultant for Edwards Lifesciences and Boston Scientific and consultant for Medtronic and Abbott Vascular. JS reports lecture fees from Edwards Lifesciences, travel compensation from Boston Scientific and Edwards Lifesciences and is a proctor for Symetis SA and JenaValve. All other authors report no conflicts of interest.